|
Yin, Dezhong; Galivan, John; Ao, Wei et al. (2003) Characterization of the human gamma-glutamyl hydrolase promoter and its gene expression in human tissues and cancer cell lines. Gene 312:281-8
|
|
Chave, Karen J; Ryan, Thomas J; Chmura, Stacey E et al. (2003) Identification of single nucleotide polymorphisms in the human gamma-glutamyl hydrolase gene and characterization of promoter polymorphisms. Gene 319:167-75
|
|
Cole, P D; Kamen, B A; Gorlick, R et al. (2001) Effects of overexpression of gamma-Glutamyl hydrolase on methotrexate metabolism and resistance. Cancer Res 61:4599-604
|
|
Sanchez-Alcazar, J A; Khodjakov, A; Schneider, E (2001) Anticancer drugs induce increased mitochondrial cytochrome c expression that precedes cell death. Cancer Res 61:1038-44
|
|
Sanchez-Alcazar, J A; Schneider, E; Martinez, M A et al. (2000) Tumor necrosis factor-alpha increases the steady-state reduction of cytochrome b of the mitochondrial respiratory chain in metabolically inhibited L929 cells. J Biol Chem 275:13353-61
|
|
Galivan, J; Ryan, T J; Chave, K et al. (2000) Glutamyl hydrolase. pharmacological role and enzymatic characterization. Pharmacol Ther 85:207-15
|
|
Chave, K J; Auger, I E; Galivan, J et al. (2000) Molecular modeling and site-directed mutagenesis define the catalytic motif in human gamma -glutamyl hydrolase. J Biol Chem 275:40365-70
|
|
Sanchez-Alcazar, J A; Ault, J G; Khodjakov, A et al. (2000) Increased mitochondrial cytochrome c levels and mitochondrial hyperpolarization precede camptothecin-induced apoptosis in Jurkat cells. Cell Death Differ 7:1090-100
|
|
Volk, E L; Rohde, K; Rhee, M et al. (2000) Methotrexate cross-resistance in a mitoxantrone-selected multidrug-resistant MCF7 breast cancer cell line is attributable to enhanced energy-dependent drug efflux. Cancer Res 60:3514-21
|
|
Galivan, J; Ryan, T; Rhee, M et al. (1999) Glutamyl hydrolase: properties and pharmacologic impact. Semin Oncol 26:33-7
|
Showing the most recent 10 out of 61 publications
